Hand Energetics

Handa Pharmaceuticals is a specialty pharmaceutical company focused on the development of high-barrier-to-entry generic and proprietary drug products. The company utilizes its proprietary drug delivery technologies, such as the ONCORE platform, to create value-added formulations of existing medications, particularly in the areas of central nervous system (CNS) disorders and oncology. Handa's business model emphasizes strategic partnerships for the commercialization of its products, which include approved treatments for schizophrenia and erosive esophagitis. By optimizing pharmacokinetic profiles and improving patient compliance, Handa aims to address unmet medical needs through enhanced therapeutic delivery systems.